News
-
Network strategy to 2028: public consultation
The draft European Medicines Agencies Network Strategy to 2028 is available for public consultation. The deadline to comment is 30 November 2024.
-Read more-
-
Speeding up Duchenne Muscular Dystrophy therapies with a model-based clinical trial simulator
Duchenne Muscular Dystrophy (DMD) is a severe genetic disorder causing muscle deterioration. Despite advances, no cure exists, and current treatments only slow progression. To support drug development, the FDA’s Critical Path Initiative and C-Path’s Duchenne Regulatory Science Consortium (D-RSC) launched a clinical trial simulation tool. This tool optimizes trials, supporting regulatory approval and speeding new therapies to market.
-Read more-
-
PhD and postdoc opportunities - October 2024
New calls with deadlines end October - early November
-Read more-
-
Are you a clinician? Fill out the survey to share your familiarity & level of adoption of in silico medicine!
In 2021, the Virtual Physiological Human Institute conducted a clinical survey among clinicians to collect feedback regarding their knowledge, experience, and opinions about CM&S in the clinical practice. Now VPHi is realising a second and much larger survey aiming at involving doctors worldwide.
-Read more-
-
Survey on Mechanical data from biological tissues
The survey aims to gather insights on the priorities and interests related to mechanical data from various tissue types and population demographics.
-Read more-
-
Celebrating Excellence: VPHi Awards at the 2024 VPH Conference in Stuttgart
Each year, the institute opens several calls to reward the outstanding research efforts of its student members, with the goal of helping them advance their academic careers and gain recognition in the field of in silico medicine.
-Read more-